» Articles » PMID: 16164041

Effects of Milk Fermented by Lactobacillus Helveticus R389 on Immune Cells Associated to Mammary Glands in Normal and a Breast Cancer Model

Overview
Journal Immunobiology
Publisher Elsevier
Date 2005 Sep 17
PMID 16164041
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Antitumour activity is an effect attributed to probiotics and fermented foods. Here, the immune cells in mammary glands and cytokine concentration in serum were analyzed using mice fed with milk fermented by Lactobacillus helveticus R389 or L89 (proteolytic-deficient variant), injected or not with breast tumour cells. Mice were fed 7 days with fermented milk, injected with breast tumour cells and 4 days post-injection, they received fermented milk. IgA, CD4, CD8, cytokines and Bcl-2 positive cells in mammary glands and cytokine in serum were determined. Mice fed with L. helveticus R389 fermented milk and injected with tumour cells increased IgA and CD4 positive cells in mammary glands (tumour control increased CD8 + cells). Mice from fermented milk control groups (without tumour cell injection) did not show changes in immune cell or cytokine positive cell numbers. IL-10 increases and IL-6 decreases were more pronounced in mice fed with milk fermented by L. helveticus R389 than in the other groups. This study demonstrated the immunoregulatory capacity of milk fermented by L. helveticus R389 on the immune response in mammary glands in presence of a local pathology (breast tumour). Orally administered fermented products could be used to modify the immune cell activation in distant mucosal sites and maintain these cells alert, but local stimulus was necessary to produce the activation of a local immune response in mammary glands, which could modulate the immune-endocrine relationship in these glands.

Citing Articles

Anti-breast cancer effects of dairy protein active peptides, dairy products, and dairy protein-based nanoparticles.

Zhang D, Yuan Y, Xiong J, Zeng Q, Gan Y, Jiang K Front Pharmacol. 2024; 15:1486264.

PMID: 39605907 PMC: 11598434. DOI: 10.3389/fphar.2024.1486264.


Nutrition Intervention and Microbiome Modulation in the Management of Breast Cancer.

Jiang Y, Li Y Nutrients. 2024; 16(16).

PMID: 39203781 PMC: 11356826. DOI: 10.3390/nu16162644.


Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine-Hydrazide Hydrazone Derivative.

Wasiak J, Glowacka P, Pudlarz A, Pieczonka A, Dzitko K, Szemraj J Molecules. 2024; 29(10).

PMID: 38792153 PMC: 11124249. DOI: 10.3390/molecules29102292.


Elucidating the roles of the mammary and gut microbiomes in breast cancer development.

Hoskinson C, Jiang R, Stiemsma L Front Oncol. 2023; 13:1198259.

PMID: 37664075 PMC: 10470065. DOI: 10.3389/fonc.2023.1198259.


Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy.

Sun J, Chen F, Wu G ISME J. 2023; 17(10):1535-1551.

PMID: 37553473 PMC: 10504269. DOI: 10.1038/s41396-023-01483-0.